84 related articles for article (PubMed ID: 16700527)
21. Novel water-soluble prodrugs of acyclovir cleavable by the dipeptidyl-peptidase IV (DPP IV/CD26) enzyme.
Diez-Torrubia A; Cabrera S; de Castro S; García-Aparicio C; Mulder G; De Meester I; Camarasa MJ; Balzarini J; Velázquez S
Eur J Med Chem; 2013; 70():456-68. PubMed ID: 24185376
[TBL] [Abstract][Full Text] [Related]
22. The effect of organ-specific CD26/DPP IV enzymatic activity inhibitor-preconditioning on acute pulmonary allograft rejection.
Jungraithmayr W; Oberreiter B; De Meester I; Wiedl T; Inci I; Bain M; Augustyns K; Hillinger S; Scharpé S; Weder W; Korom S
Transplantation; 2009 Aug; 88(4):478-85. PubMed ID: 19696630
[TBL] [Abstract][Full Text] [Related]
23. Ischemia/reperfusion injury: The role of CD26/dipeptidyl-peptidase-IV-inhibition in lung transplantation.
Zhai W; Cardell M; De Meester I; Augustyns K; Hillinger S; Inci I; Arni S; Jungraithmayr W; Scharpé S; Weder W; Korom S
Transplant Proc; 2006 Dec; 38(10):3369-71. PubMed ID: 17175274
[TBL] [Abstract][Full Text] [Related]
24. [Histochemical activity of dipeptidyl peptidase IV (DPP IV) in intracerebral transplantation of the submandibular gland in mice].
Pospísilová B; Procházková O; Slízová D; Bílek P; Krs O
Acta Medica (Hradec Kralove) Suppl; 1998; 41(1):11-7. PubMed ID: 10103157
[TBL] [Abstract][Full Text] [Related]
25. Expression of CD26 and its association with dipeptidyl peptidase IV activity in lymphocytes of type 2 diabetes patients.
Bellé LP; Bitencourt PE; de Bona KS; Zanette RA; Moresco RN; Moretto MB
Cell Biochem Biophys; 2011 Nov; 61(2):297-302. PubMed ID: 21614532
[TBL] [Abstract][Full Text] [Related]
26. Development and resolution of colitis in mice with target deletion of dipeptidyl peptidase IV.
Detel D; Pugel EP; Pucar LB; Buljevic S; Varljen J
Exp Physiol; 2012 Apr; 97(4):486-96. PubMed ID: 22125312
[TBL] [Abstract][Full Text] [Related]
27. [Development of dipeptidyl peptidase IV (DPP IV) activity in postnatal differentiation of the submandibular gland in mice].
Pospísilová B; Procházková O; Slízvá D; Bílek P; Krs O
Acta Medica (Hradec Kralove) Suppl; 1998; 41(1):3-9. PubMed ID: 10103156
[TBL] [Abstract][Full Text] [Related]
28. CD26/dipeptidylpeptidase IV-targeted therapy of acute lung rejection in rats.
Jung FJ; Yang L; De Meester I; Augustyns K; Cardell M; Hillinger S; Vogt P; Lardinois D; Scharpé S; Weder W; Korom S
J Heart Lung Transplant; 2006 Sep; 25(9):1109-16. PubMed ID: 16962474
[TBL] [Abstract][Full Text] [Related]
29. Critical role of renal dipeptidyl peptidase-4 in ameliorating kidney injury induced by saxagliptin in Dahl salt-sensitive hypertensive rats.
Sakai M; Uchii M; Myojo K; Kitayama T; Kunori S
Eur J Pharmacol; 2015 Aug; 761():109-15. PubMed ID: 25936515
[TBL] [Abstract][Full Text] [Related]
30. (2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor.
Tajima A; Yamamoto K; Kozakai A; Okumura-Kitajima L; Mita Y; Kitano K; Jingu S; Nakaike S
Eur J Pharmacol; 2011 Mar; 655(1-3):99-107. PubMed ID: 21262219
[TBL] [Abstract][Full Text] [Related]
31. RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes.
Singh S; Roy S; Sethi S; Benjamin B; Sundaram S; Khanna V; Kandalkar SR; Pal C; Kant R; Patra AK; Rayasam G; Mittra S; Saini KS; Paliwal J; Chugh A; Ahmed S; Sattigeri J; Cliff I; Ray A; Bansal VS; Bhatnagar PK; Davis JA
Eur J Pharmacol; 2011 Feb; 652(1-3):157-63. PubMed ID: 20540938
[TBL] [Abstract][Full Text] [Related]
32. A general method for making peptide therapeutics resistant to serine protease degradation: application to dipeptidyl peptidase IV substrates.
Heard KR; Wu W; Li Y; Zhao P; Woznica I; Lai JH; Beinborn M; Sanford DG; Dimare MT; Chiluwal AK; Peters DE; Whicher D; Sudmeier JL; Bachovchin WW
J Med Chem; 2013 Nov; 56(21):8339-51. PubMed ID: 24044354
[TBL] [Abstract][Full Text] [Related]
33. Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells.
Reinhold D; Bank U; Bühling F; Kähne T; Kunt D; Faust J; Neubert K; Ansorge S
Immunobiology; 1994 Dec; 192(1-2):121-36. PubMed ID: 7750986
[TBL] [Abstract][Full Text] [Related]
34. Primary graft dysfunction in lung transplantation: the role of CD26/dipeptidylpeptidase IV and vasoactive intestinal peptide.
Zhai W; Jungraithmayr W; De Meester I; Inci I; Augustyns K; Arni S; Hillinger S; Scharpé S; Weder W; Korom S
Transplantation; 2009 Apr; 87(8):1140-6. PubMed ID: 19384159
[TBL] [Abstract][Full Text] [Related]
35. The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes.
Deng J; Peng L; Zhang G; Lan X; Li C; Chen F; Zhou Y; Lin Z; Chen L; Dai R; Xu H; Yang L; Zhang X; Hu W
Eur J Med Chem; 2011 Jan; 46(1):71-6. PubMed ID: 21106276
[TBL] [Abstract][Full Text] [Related]
36. Dipeptidyl peptidase IV in the hypothalamus and hippocampus of monosodium glutamate obese and food-deprived rats.
Alponti RF; Frezzatti R; Barone JM; Alegre Vde S; Silveira PF
Metabolism; 2011 Feb; 60(2):234-42. PubMed ID: 20153005
[TBL] [Abstract][Full Text] [Related]
37. Concentration-dependent plasma protein binding of the novel dipeptidyl peptidase 4 inhibitor BI 1356 due to saturable binding to its target in plasma of mice, rats and humans.
Fuchs H; Tillement JP; Urien S; Greischel A; Roth W
J Pharm Pharmacol; 2009 Jan; 61(1):55-62. PubMed ID: 19126297
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the susceptibility of porcine and human dipeptidyl-peptidase IV to inhibition by protein-derived peptides.
Lacroix IM; Li-Chan EC
Peptides; 2015 Jul; 69():19-25. PubMed ID: 25828735
[TBL] [Abstract][Full Text] [Related]
39. Structure based virtual screening of MDPI database: discovery of structurally diverse and novel DPP-IV inhibitors.
Tanwar O; Tanwar L; Shaquiquzzaman M; Alam MM; Akhter M
Bioorg Med Chem Lett; 2014 Aug; 24(15):3447-51. PubMed ID: 24948564
[TBL] [Abstract][Full Text] [Related]
40. Quaternary benzo[c]phenanthridine alkaloids as inhibitors of dipeptidyl peptidase IV-like activity baring enzymes in human blood plasma and glioma cell lines.
Sedo A; Malík R; Vicar J; Simánek V; Ulrichová J
Physiol Res; 2003; 52(3):367-72. PubMed ID: 12790770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
